All Type of News
1999 perspective in drug industry: Drug distribution reform plan.
The MOHW announced the drug distribution reform for the purpose of eliminating irrational drug purchasing practices between the drug suppliers and hospitals, stimulating the pharmaceutical industrial restructuring and...
1999 perspective in drug industry: Hospital irrational practice in drug purchasing.
Because of over supply of drugs and thereby severe competition among the drug manufacturers and suppliers, there appeared with ongoing incidences of irrational drug purchasing practices between hospitals and drug make...
1999 perspective in drug industry: KGSP approval.
As of Dec. 30 the total 126 wholesalers have passed the KGSP requirements, which was about 30% of 430 wholesalers across the nation. Starting from Woojung Wholesaler (Chairman: Choi Min-il), over 120 wholesalers have ...
1999 perspective in drug industry: Drug revaluation and PMS
The new drug revaluation system implemented from 1995 seems to be substantially eased and converted to the PMS (Post marketing surveillance) after strengthening the revaluation and the monitoring of drug adverse react...
1999 perspective in drug industry: Enactment of consolidated narcotic law
In line with deregulation reforms the current narcotic law, the psychotropic drug control law and the marijuana control law will be consolidated into "The narcotics and the like control law", eliminating unnecessary r...
1999 perspective in drug industry: Medical/pharmacy separation system and pharmacy management.
The separation system of the medical and pharmacy practice as scheduled to implement from July 1, 1999 will play as an important factor for changing the environement of the pharmacy market and advancing the time of ph...
1999 perspective in drug industry: Medical/pharmacy sparation system and marketing.
The pharmaceutical industry should reallocate their sales representatives along with their re-education at the time of the medical and pharmacy separation system being implemented. The marketing strategy will be focus...
1999 perspective in drug industry: Toxicity test standards.
The KFDA, the National Institute of Toxicology revised the toxicity test standards for drug etc. and announced on Dec. 16 in order to meet an appropriate safety evaluation of drugs and other chemical substances in lin...
1999 perspective in drug industry: Bioequivalency test standards.
The KFDA announced the revised provisions concerning the new standards for bioequivalent test containing the extension of qualified institutes of test to all medical institutes and the increased number of test examine...
1999 perspective in drug industry: Revised Medical Affairs Law.
The government prepared the revised draft of the Medical Affairs Law in line with the deregulation and reform plans for the purpose of enhancing efficiency of the medical service for people, and presented it to the He...
